中医辨证联合抗病毒治疗对乙型肝炎肝硬化失代偿发生率的影响
作者:
作者单位:

上海中医药大学附属曙光医院,上海 200021

作者简介:

通讯作者:

中图分类号:

R259

基金项目:

* 基金项目: 陈建杰上海市名中医工作室(ZYSNXD.cc—MZY003);中管局重点学科建设——中医传染病学
收稿日期: 2017 - 04- 18
作者简介: 董亚男(1988-),女,河北沧州人,在读博士研究生,研究方向:中医药治疗肝病。
△通信作者:陈建杰,Email:jianjie_chen@hotmail.com


The Impact of the TCM Syndrome Differentiation Treatment Combined with Antiviral Treatmenton the Incidence of HBV Related Decompensated Liver Cirrhosis
Author:
Affiliation:

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200021, China

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
    摘要:

    目的 研究中医辨证论治联合抗病毒治疗乙型肝炎肝硬化代偿期患者的失代偿累积发病率,并探究失代偿发生的相关影响因素。方法 采用回顾性队列研究,收集4个分中心共计453例乙型肝炎肝硬化代偿期患者,根据是否接受中医辨证论治治疗,分为中西医结合队列(中医辨证论治联合抗病毒治疗组)和西医队列(单纯抗病毒治疗组)(226例 vs 227例)。观察两队列间肝硬化失代偿的累积发病率,并探究其发生的相关影响因素。结果 治疗第3、5年,中西医结合队列和西医队列的乙型肝炎肝硬化失代偿的累积发病率分别为4.42% vs 18.5%和5.31% vs 21.59%,差别均有统计学意义(P<0.05)。辨证论治联合抗病毒治疗方案可以减少肝硬化失代偿的发生率7.63%以上。两队列腹水和食管胃底静脉曲张破裂出血的发生率分别为4.87% vs 17.62%和0.44% vs 5.29%,差别均有统计学意义(P<0.05)。发生乙型肝炎肝硬化失代偿的相关影响因素可能有:年龄大于50岁(OR=2.744,95%CI=1.521-4.950)、有过敏史(OR=2.148,95%CI=1.016-4.543)、家族史(OR=1.833,95%CI=1.108-3.035)、基线HBsAg数值大于1000(OR=2.294,95%CI=1.307-4.027)、发生影像学改善(OR=0.077,95%CI=0.011-0.557)等。结论 乙型肝炎肝硬化代偿期患者接受中医辩证论治联合抗病毒治疗,可以一定程度上减少肝硬化失代偿的累积发病率。发生影像学改善可能是肝硬化代偿期患者的保护因素,年龄大于50岁、有过敏史、家族史、基线HBsAg数值大于1000可能是发生肝硬化失代偿的危险因素。

    Abstract:

    Objective To observe the clinical efficacy of the TCM syndrome differentiation treatment combined with antiviral treatment in HBV related compensated liver cirrhosis patients. Explore the related causative factors of the happening of decompensated liver cirrhosis. Methods In accordance with the method of retrospective cohort study, a total of 453 patients of compensated liver cirrhosis are divided into integrated Chinese and Western medicine cohort(TCM therapy and antiviral therapy) and Western medicine cohort(single antiviral treatment)(226 cases vs 227 cases) according to whether or not to accept the treatment of TCM. Observe and explore the accumulation incidence rates and the related causative factors of the happening of decompensated liver cirrhosis. Results In the third and fifth year, the accumulation incidence rates of decompensated liver cirrhosis of the integrated Chinese and western medicine cohort and the western medicine cohort are 4. 42% and 18.5%, 5.31% and 21.59% respectively, the differences have statistical significance(P<0.05). The TCM syndrome differentiation treatment combined with antiviral treatment can reduce the incidence rate of decompensated liver cirrhosis by more than 7.63%. The incidence rates of ascites and esophagogastric variceal bleeding(EGVB) of the two cohorts are 4.42% and 18.5%, 5.31% and 21.59% respectively, the differences have statistical significance(P<0.05). The related influence factors of decompensated cirrhosis happening might be older than 50 years(OR=2.744, 95%CI=1.521-4.950), and having history of allergies(OR=2.148, 95%CI=1.016-4.543), family(OR=1.833, 95%CI=1.108-3.035), baseline HBsAg values higher than 1000(OR=2.294, 95%CI=1.307-4.027) and imaging improvement(OR=0.077, 95%CI=0.011-0.557), etc. Conclusion The TCM syndrome differentiation treatment combined with antiviral treatment has good clinical effect, can reduce the cumulative incidence of decompensated liver cirrhosis to a certain extent. Imaging improvement may be the protection factor of HBV related compensated liver cirrhosis patients. Older than 50 years, and has allergies, family history and baseline HBsAg values higher than 1000 may be the risk factors of the liver decompensation cirrhosis.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期:
  • 出版日期:

温馨提示

关闭